Baird Medical Investment Holdings Limited (BDMD)
NASDAQ: BDMD · Real-Time Price · USD
1.680
-0.070 (-4.00%)
At close: Apr 28, 2026, 4:00 PM EDT
1.680
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:04 PM EDT
BDMD Revenue
In the year 2025, Baird Medical Investment Holdings had annual revenue of $22.54M, down -39.15%. Baird Medical Investment Holdings had revenue of $7.96M in the half year ending June 30, 2025, a decrease of -31.06%.
Revenue (ttm)
$22.54M
Revenue Growth
-39.15%
P/S Ratio
2.79
Revenue / Employee
$157,602
Employees
143
Market Cap
61.70M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Accuray | 436.97M |
| Xtant Medical Holdings | 133.93M |
| Outset Medical | 119.48M |
| LENSAR | 58.44M |
| Sensus Healthcare | 27.48M |
| Spectral AI | 19.65M |
| QT Imaging Holdings | 18.93M |
| InspireMD | 8.98M |
BDMD News
- 6 weeks ago - Baird Medical Advances Clinical Education with Expert-Led Workshops in Indonesia - PRNewsWire
- 6 weeks ago - Baird Medical Expands Global Reach with Regulatory Clearance in Argentina - PRNewsWire
- 7 weeks ago - Baird Medical Accelerates U.S. Expansion in Interventional Thyroidology at NASIT 2026 - PRNewsWire
- 7 weeks ago - Baird Medical Accelerates Global Registration of AI-Driven Surgical Software - PRNewsWire
- 2 months ago - Baird Medical Accelerates U.S. Expansion at NASOIE 2026 - PRNewsWire
- 2 months ago - Baird Medical Accelerates U.S. Expansion in Interventional Thyroidology - PRNewsWire
- 2 months ago - Baird Medical to Showcase Minimally Invasive Thyroid Solutions at Upcoming US Clinical Conferences - PRNewsWire
- 2 months ago - Baird Medical Drives U.S. Market Penetration with Commercial Launch at Bakersfield Memorial Hospital - PRNewsWire